Tavo profilaktika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,915 | 1,637 | - | 114,524 | 1,597,887 | 4,252,445 | 6,474,135 | 8,074,814 |
| Profit before tax | 1,489 | 241 | -878 | -399,592 | -844,705 | -1,045,778 | -864,707 | -1,407,865 |
| Net profit | 1,266 | 205 | -878 | -399,592 | -844,705 | -1,045,778 | -731,533 | -1,399,322 |
| Equity | 3,577 | 3,783 | 2,905 | -396,687 | -1,241,392 | -2,287,170 | -2,768,137 | -4,167,459 |
| Liabilities | 253 | 126 | 36 | 1,104,683 | 2,362,247 | 3,922,633 | 6,897,243 | 6,563,079 |
| Non-current assets | 0 | 0 | 0 | 417,855 | 1,000,720 | 1,090,552 | 1,635,355 | 1,473,925 |
| Current assets | 3,750 | 3,909 | 2,941 | 290,141 | 118,694 | 542,167 | 2,469,422 | 1,018,280 |
| Total assets | 3,750 | 3,909 | 2,941 | 707,996 | 1,119,414 | 1,632,719 | 4,104,777 | 2,492,205 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 403,908 | 567,486 | 926,659 |
| Social insurance contributions | - | - | - | - | - | 463,663 | 732,083 | 961,528 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | -43.8% | - | - | +1295.2% | +166.1% | +52.2% | +24.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 33.8% | 5.2% | -29.9% | -56.4% | -75.5% | -64.1% | -17.8% | -56.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 35.4% | 5.4% | -30.2% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 43.4% | 12.5% | - | -348.9% | -52.9% | -24.6% | -11.3% | -17.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 51.1% | 14.7% | - | -348.9% | -52.9% | -24.6% | -13.4% | -17.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.0 | 0.0 | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,458 | 1,501 | - | 4,643 | 24,210 | 33,952 | 38,709 | 34,943 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Tavo profilaktika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 1019.68 |
| 2026-08-19 | 2026-08-19 | 1019.68 |
| 2021-09-16 | 2021-09-19 | 1691.05 |
Tavo profilaktika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-17 | 2026-03-18 | 34.11 |
| 2026-03-13 | 2026-03-16 | 33.97 |
| 2025-11-14 | 2025-11-14 | 1763.48 |
| 2025-11-12 | 2025-11-13 | 1757.9 |
| 2025-04-11 | 2025-04-16 | 1422.11 |
| 2024-11-21 | 2024-11-26 | 496.31 |
| 2024-11-20 | 2024-11-20 | 496.45 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Tavo profilaktika, UAB (code 304499144) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, the company generated €8.07M in revenue, up 24.7% year on year and 89.9% compared with 2023. Despite this growth, it reported a net loss of €1.40M, with a profit margin of -17.3%. The loss was larger than in 2024, when net loss amounted to €731.5K, but smaller than the €1.05M loss recorded in 2023. The three-year pattern shows rapidly increasing turnover alongside continued operating losses. At the end of 2025, total assets stood at €2.49M, with long-term assets of €1.47M and short-term assets of €1.02M. Equity remained deeply negative at -€4.17M, while liabilities were €6.56M. Because equity is negative, return and leverage ratios are distorted and should be interpreted cautiously. Asset turnover was 3.24x, indicating high revenue generation relative to asset base. Revenue per employee was €35.0K, while profit per employee was -€6.1K.